Business
PRTC Presents at Jefferies Healthcare Conference
PRTC Presents at Jefferies Healthcare Conference.
About this update from Puretech Health Plc
[{"type":"text","content":"\n \n \n \n RNS Number : 6527Z\n PureTech Health PLC\n 25 May 2021\n \n \n \n \n 25 May 2021\n \n \n PureTech Health plc\n \n \n \n \n \n \n PureTech\n \n \n to Present at the Jefferies Virtual Healthcare Conference\n \n \n \n \n \n \n \n \n PureTech Health plc\n \n \n (Nasdaq: PRTC, LSE: PRTC) (\"PureTech\" or the \"Company\"), a clinical-stage biotherapeutics company dedicated to discovering, developing and commercializing highly differentiated medicines for devastating diseases, today announced that Daphne Zohar, Founder and CEO, will participate in a fireside chat at the Jefferies Virtual Healthcare Conference on Wednesday, June 2nd at 9:00 AM EST. A webcast of the presentation will be available at \n \n \n https://investors.puretechhealth.com/events-presentations\n \n \n . \n \n \n \n \n \n About PureTech Health\n \n \n PureTech is a clinical-stage biotherapeutics company dedicated to discovering, developing and commercializing highly differentiated medicines for devastating diseases, including inflammatory, fibrotic and immunological conditions, intractable cancers, lymphatic and gastrointestinal diseases and neurological and neuropsychological disorders, among others. The Company has created a broad and deep pipeline through the expertise of its experienced research and development team and its extensive network of scientists, clinicians and industry leaders. This pipeline, which is being advanced both internally and through PureTech's Founded Entities, is comprised of 26 therapeutics and therapeutic candidates, including two that have received FDA clearance and European marketing authorization, as of the date of PureTech's most recently filed Annual Report on Form 20-F. All of the underlying programs and platforms that resulted in this pipeline of therapeutic candidates were initially identified or discovered and then advanced by the PureTech team through key validation points based on the Company's unique insights into the biology of the brain, immune and gut, or BIG, systems and the interface between those systems, referred to as the BIG Axis.\n \n \n \n \n \n For more information, visit www.puretechhealth.com or connect with us on Twitter @puretechh.\n \n \n \n \n \n Cautionary Note Regarding Forward-Looking Statements\n \n \n This ...